Loading clinical trials...
Loading clinical trials...
An Open, Single-center, Phase II Trial of Cadonilimab Combined With Platinum-containing Dual-agent Neoadjuvant Therapy for Locally Advanced Operable Head and Neck Squamous Cell Carcinoma
Conditions
Interventions
Cadonilimab
Docetaxel
+1 more
Locations
2
China
Sun Yat-sen University Cancer Center, 651 Dongfeng East Road
Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center, 651 Dongfeng East Road
Guangzhou, China
Start Date
July 19, 2023
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
September 5, 2023
NCT06980038
NCT05039801
NCT06806852
NCT05526924
NCT05977907
NCT02734537
Lead Sponsor
Xuekui Liu
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions